Open Menu Close Menu


Published by Sara Phillips | 2017-10-20 10:00:06

Found in: AcceleratorbiotechCTA@BostonLife SciencesTechnology 

iBIONICS is disrupting the biotechnology industry with The Diamond Eye, cutting-edge technology offering a visionary solution to blindness.

iBIONICS delivers health solutions by designing, manufacturing and commercializing implantable bionic solutions that treat debilitating diseases. The iBIONICS Diamond Eye solution aims to restore vision enabling the blind to regain autonomy, recognize faces, and read large print. The iBIONICS Diamond Eye uses diamond electrodes to stimulate the retina, sending messages to the brain that are perceived as light. This leading technology designed to return autonomy and partial vision to the blind is supported by a state-of-the-art wireless solution for implantable bionic devices.

In 2016, iBIONICS won Startup Canada’s National Innovation Award for its work in developing a solution for blindness. The Startup Canada Innovation Award is awarded to a Canadian company exhibiting excellence in innovation through leveraging new knowledge or technology in solving real world problems.

iBIONICS is currently in residence at the Canadian Technology Accelerator in Boston (CTA@Boston) as part of the Accelerator’s fall cohort. On November 1, company CEO Suzanne Grant will participate in the Canadian tech pitch session, Meet the Disruptors, in downtown Boston. Interested in seeing iBIONICS there? Contact CTA@Boston Trade Commissioner Christine Sarkisian for more information.

Share this Post